OBI Pharma与GlyTech合作,在日本推广和销售癌症药物的甘油技术。 OBI Pharma partners with GlyTech to advance and market glycan technologies for cancer drugs in Japan.

OBI Pharma是一家以台湾为基地的肿瘤公司,与日本的GlyTech合作,在日本推销OBI的GlycOBI ADC技术,并为抗体药物共产品提前生产甘油。 OBI Pharma, a Taiwan-based oncology company, has partnered with Japan's GlyTech to market OBI's GlycOBI® ADC technologies in Japan and advance glycan production for antibody-drug conjugates. GlyTech将提供甘油并推广OBI的技术,而OBI将转让先进研究材料。 GlyTech will supply glycans and promote OBI's technologies, while OBI will transfer advanced materials for research. 这项合作旨在扩大OBI技术的覆盖范围,改进ADC的甘油制造。 This collaboration aims to expand the reach of OBI's technologies and improve glycan manufacturing for ADCs.